RxNorm Semantic Concepts Index - 618
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "618".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 6180 | Kynurenin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 6180 | Kynurenin | Designated preferred name (PT) | NO | |
| RxCUI: 6180 | Kynurenin | Full form of descriptor (FN) | NO | |
| RxCUI: 618000 | amoxicillin 25 MG/ML / clavulanate 12.4 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618001 | amoxicillin 100 MG/ML / clavulanate 12.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618002 | amoxicillin 100 MG/ML / clavulanate 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618003 | amoxicillin 20 MG/ML / clavulanate 2.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618025 | bacitracin 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618026 | bacitracin 10000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618027 | amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML [Augmentin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 618028 | AUGMENTIN ES 600 MG / 42.9 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 618028 | AUGMENTIN ES 600 MG / 42.9 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618028 | AUGMENTIN ES 600 MG / 42.9 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618028 | AUGMENTIN ES 600 MG / 42.9 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618037 | amoxicillin 1000 MG / clavulanate 62.5 MG [Augmentin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 618038 | amoxicillin / clavulanate Extended Release Oral Tablet [Augmentin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 618039 | amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet [Augmentin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 618045 | neomycin 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618046 | neomycin 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618049 | erythromycin Oral Suspension [Ilosone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 61805 | nitisinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 61805 | nitisinone | Designated preferred name (PT) | YES | |
| RxCUI: 61805 | nitisinone | Full form of descriptor (FN) | YES | |
| RxCUI: 61805 | nitisinone | Designated preferred name (PT) | YES | |
| RxCUI: 61805 | nitisinone | Full form of descriptor (FN) | YES | |
| RxCUI: 618050 | erythromycin estolate 50 MG/ML Oral Suspension [Ilosone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 618050 | erythromycin estolate 50 MG/ML Oral Suspension [Ilosone] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618060 | thioctate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 618062 | thioctate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618067 | thioctate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618070 | thioctate Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618077 | thiamine / thioctate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618080 | thioctate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618089 | nystatin 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618090 | nystatin 10000 UNT/ML / triamcinolone 1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 6181 | L-glucose | Designated preferred name (PT) | NO | |
| RxCUI: 6181 | L-glucose | Full form of descriptor (FN) | NO | |
| RxCUI: 618127 | thioctate / vitamin B12 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618130 | acetylcarnitine / thioctate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618132 | rifampin 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618132 | rifampin 3 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618133 | rifampin 3 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618133 | rifampin 3 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 61822 | Retinene isomerase | Designated preferred name (PT) | NO | |
| RxCUI: 61822 | Retinene isomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 61822 | Retinene isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618249 | mefenamate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618252 | mefenamate Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618255 | acetaminophen / chlorpheniramine / dextromethorphan Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618257 | aminobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618259 | aminobutyrate / phenobarbital / phenytoin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618259 | aminobutyrate / phenobarbital / phenytoin Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618269 | benzoyl peroxide 75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618272 | flufenamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618273 | flufenamate 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618274 | chlorzoxazone / flufenamate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618275 | chlorzoxazone 125 MG / flufenamate 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618278 | azelate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 618280 | azelate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618283 | azelate Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618285 | guaiFENesin 800 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618285 | guaiFENesin 800 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618285 | guaiFENesin 800 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618285 | guaiFENesin 800 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618285 | guaiFENesin 800 MG / phenylephrine HCl 40 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618290 | chloroacetate 800 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618291 | chloroacetate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618292 | chloroacetate 80 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618292 | chloroacetate 80 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618292 | chloroacetate 80 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618293 | chloroacetate 820 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618294 | chloroacetate 820 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618295 | dichloroacetate 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618296 | dichloroacetate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618297 | dichloroacetate 1000 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618328 | deoxycholate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618329 | deoxycholate / pepsin A Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618330 | deoxycholate 100 MG / pepsin A 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618333 | chlorpheniramine tannate 1.6 MG/mL / phenylephrine tannate 3 MG/mL / pyrilamine tannate 2.5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618333 | chlorpheniramine tannate 1.6 MG/mL / phenylephrine tannate 3 MG/mL / pyrilamine tannate 2.5 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618335 | oleate / polidocanol Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618338 | oleate / polidocanol Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618342 | butacaine / oleate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618347 | boric acid / oleate Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618349 | acetaminophen / guaifenesin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618349 | acetaminophen / guaifenesin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618350 | APAP 500 MG / guaifenesin 200 MG per 15 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618350 | APAP 500 MG / guaifenesin 200 MG per 15 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618350 | APAP 500 MG / guaifenesin 200 MG per 15 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618350 | APAP 500 MG / guaifenesin 200 MG per 15 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618350 | APAP 500 MG / guaifenesin 200 MG per 15 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618350 | APAP 500 MG / guaifenesin 200 MG per 15 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618361 | glycolate / pyruvate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618364 | ubidecarenone 50 MG / vitamin E 5 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618364 | ubidecarenone 50 MG / vitamin E 5 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618364 | ubidecarenone 50 MG / vitamin E 5 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618365 | synthetic conjugated estrogens, B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618366 | synthetic conjugated estrogens, B 0.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618367 | synthetic conjugated estrogens, B Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618368 | synthetic conjugated estrogens, B 0.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618368 | synthetic conjugated estrogens, B 0.3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618369 | synthetic conjugated estrogens, B 0.45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618370 | synthetic conjugated estrogens, B 0.45 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618370 | synthetic conjugated estrogens, B 0.45 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618371 | pentetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618373 | pentetate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618375 | synthetic conjugated estrogens, B 0.625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618376 | synthetic conjugated estrogens, B 0.625 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618376 | synthetic conjugated estrogens, B 0.625 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618377 | synthetic conjugated estrogens, B 1.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618378 | synthetic conjugated estrogens, B 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618378 | synthetic conjugated estrogens, B 1.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618381 | pipemidate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618383 | pipemidate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618386 | mefenamate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618388 | mefenamate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618391 | mefenamate Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618404 | pipemidate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618407 | linoleate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618420 | linoleate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618421 | linoleate / sunflower oil Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618422 | linoleic acid 500 MG / sunflower oil 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618422 | linoleic acid 500 MG / sunflower oil 1000 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618425 | nalidixate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618426 | nalidixate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618427 | nalidixate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618430 | nalidixate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618438 | nalidixate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618440 | nalidixate / phenazopyridine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618441 | nalidixate 500 MG / phenazopyridine 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618442 | tiaprofenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618443 | tiaprofenate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618444 | tiaprofenate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618445 | tiaprofenic acid 200 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 618445 | tiaprofenic acid 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618445 | tiaprofenic acid 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618445 | tiaprofenic acid 200 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 618446 | tiaprofenate 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618447 | tiaprofenate 300 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 618447 | tiaprofenate 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618447 | tiaprofenate 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618447 | tiaprofenate 300 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 618448 | tiaprofenate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618449 | tiaprofenate 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618451 | tiaprofenate Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618452 | tiaprofenate 300 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618453 | gamma-linolenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618456 | gamma-linolenate / linoleate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618458 | tiaprofenate Extended Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618459 | tiaprofenate 300 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618461 | tiaprofenic acid 300 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618461 | tiaprofenic acid 300 MG 24HR Extended Release Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 618461 | tiaprofenic acid 300 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618461 | tiaprofenic acid 300 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618461 | tiaprofenic acid 300 MG 24HR Extended Release Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 618462 | gamma-linolenate 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618465 | linoleate 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618466 | linoleate 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618467 | chenodeoxycholate 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618468 | chenodeoxycholate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618469 | chenodiol 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618469 | chenodiol 250 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 618469 | chenodiol 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618469 | chenodiol 250 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 618473 | chenodeoxycholate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618478 | linoleate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618480 | chenodeoxycholate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618481 | linoleate 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618482 | ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618483 | ricinoleate 2.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618484 | linoleate / ricinoleate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618485 | linoleate 8 MG/ML / ricinoleate 2.1 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618487 | linoleate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618490 | chenodeoxycholate / ursodeoxycholate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618496 | chenodeoxycholate / ursodeoxycholate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618498 | gamma-linolenate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618499 | gamma-linolenate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 6185 | Labetalol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 6185 | Labetalol | Designated preferred name (PT) | YES | |
| RxCUI: 6185 | Labetalol | Full form of descriptor (FN) | YES | |
| RxCUI: 6185 | Labetalol | Designated preferred name (PT) | YES | |
| RxCUI: 6185 | Labetalol | Full form of descriptor (FN) | YES | |
| RxCUI: 618500 | gamolenic acid 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618500 | gamolenic acid 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618500 | gamolenic acid 40 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 618500 | gamolenic acid 40 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 618501 | gamma-linolenate 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618502 | gamolenic acid 80 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618502 | gamolenic acid 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618502 | gamolenic acid 80 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 618502 | gamolenic acid 80 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 618504 | ursodeoxycholate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618509 | gamma-linolenate 260 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618510 | gamma-linolenate / vitamin E Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618511 | gamma-linolenate 260 MG / vitamin E 1.5 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618512 | ursodeoxycholate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618514 | gamma-linolenate 130 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618515 | gamma-linolenate 130 MG / vitamin E 10 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618520 | gamma-linolenate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618521 | gamma-linolenate 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618527 | evening primrose oil / gamma-linolenate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618528 | evening primrose oil 365 MG / gamma linolenic acid 45 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618528 | evening primrose oil 365 MG / gamma linolenic acid 45 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618530 | gamma-linolenate 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618531 | gamma-linolenate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618532 | gamolenic acid 20 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618532 | gamolenic acid 20 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618532 | gamolenic acid 20 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618534 | ursodeoxycholate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618536 | gamma-linolenate 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618537 | gamma-linolenate 90 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618549 | gamma-linolenate 45 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618550 | meclofenamate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618551 | meclofenamate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618552 | meclofenamate sodium 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618552 | meclofenamate sodium 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618552 | meclofenamate sodium 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618552 | meclofenamate sodium 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 618552 | meclofenamate sodium 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 618553 | fusidate 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618554 | fusidate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618555 | sodium fusidate 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618555 | sodium fusidate 250 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 618555 | sodium fusidate 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618555 | sodium fusidate 250 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 618556 | meclofenamate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618557 | meclofenamate sodium 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618557 | meclofenamate sodium 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618557 | meclofenamate sodium 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618557 | meclofenamate sodium 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 618557 | meclofenamate sodium 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 618558 | meclofenamate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618559 | meclofenamate 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618560 | meclofenamate 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618561 | fusidate 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618562 | fusidate Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618563 | fusidate 250 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618563 | fusidate 250 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618563 | fusidate 250 MG per 5 ML Oral Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 618563 | fusidate 250 MG per 5 ML Oral Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 618564 | trichloroacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 618565 | trichloroacetate 800 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618566 | trichloroacetate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618567 | trichloroacetate 80 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618567 | trichloroacetate 80 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618567 | trichloroacetate 80 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618568 | fusidate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618569 | fusidate Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618570 | fusidate 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618570 | fusidate 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618570 | fusidate 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618575 | fusidate 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618576 | fusidate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618577 | fusidic acid 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618577 | fusidic acid 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618577 | fusidic acid 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618577 | fusidic acid 2 % Topical Cream | Designated preferred name (PT) | NO | |
| RxCUI: 618577 | fusidic acid 2 % Topical Cream | Full form of descriptor (FN) | NO | |
| RxCUI: 618578 | trichloroacetate 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618579 | trichloroacetate 50 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618579 | trichloroacetate 50 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618579 | trichloroacetate 50 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618580 | fusidate 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618581 | fusidate Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618582 | sodium fusidate 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618582 | sodium fusidate 2 % Topical Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 618582 | sodium fusidate 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618582 | sodium fusidate 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618582 | sodium fusidate 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618582 | sodium fusidate 2 % Topical Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 618583 | trichloroacetate 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618584 | trichloroacetate 30 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618584 | trichloroacetate 30 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618587 | fusidate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618589 | fusidate Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618590 | fusidate 250 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618593 | fusidate 49.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618594 | fusidate 49.2 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618595 | fusidate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618596 | fusidate 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618597 | Eicosapentaenoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 618597 | Eicosapentaenoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618598 | eicosapentaenoate 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618602 | fusidate 35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618603 | fusidate 35 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618606 | docosahexaenoate / eicosapentaenoate / vitamin E Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618608 | docosahexaenoate / eicosapentaenoate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618610 | fusidate / hydrocortisone Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618611 | fusidate 2 % / hydrocortisone 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618611 | fusidate 2 % / hydrocortisone 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618611 | fusidate 2 % / hydrocortisone 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618611 | fusidate 2 % / hydrocortisone 1 % Topical Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 618611 | fusidate 2 % / hydrocortisone 1 % Topical Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 618612 | docosahexaenoate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618613 | borage oil / docosahexaenoate / eicosapentaenoate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618614 | borage oil 56 MG / docosahexaenoate 40 MG / eicosapentaenoate 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618615 | betamethasone / fusidate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618616 | betamethasone 0.1 % / fusidate 2 % Topical Cream | Designated preferred name (PT) | NO | |
| RxCUI: 618616 | betamethasone 0.1 % / fusidate 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618616 | betamethasone 0.1 % / fusidate 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618616 | betamethasone 0.1 % / fusidate 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618616 | betamethasone 0.1 % / fusidate 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618616 | betamethasone 0.1 % / fusidate 2 % Topical Cream | Full form of descriptor (FN) | NO | |
| RxCUI: 618619 | glutamate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618620 | glutamate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618621 | glutamate 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618622 | fusidate / hydrocortisone Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618623 | hydrocortisone acetate 1 % / fusidic acid 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618623 | hydrocortisone acetate 1 % / fusidic acid 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618623 | hydrocortisone acetate 1 % / fusidic acid 2 % Topical Cream | Designated preferred name (PT) | NO | |
| RxCUI: 618623 | hydrocortisone acetate 1 % / fusidic acid 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618623 | hydrocortisone acetate 1 % / fusidic acid 2 % Topical Cream | Full form of descriptor (FN) | NO | |
| RxCUI: 618624 | glutamate 205 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618625 | glutamate / magnesium citrate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618626 | glutamate 205 MG / magnesium citrate 90 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618627 | fusidate Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618628 | fusidate 2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618628 | fusidate 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618628 | fusidate 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618628 | fusidate 2 % Topical Gel | Designated preferred name (PT) | NO | |
| RxCUI: 618628 | fusidate 2 % Topical Gel | Full form of descriptor (FN) | NO | |
| RxCUI: 618629 | glutamate 340 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618630 | glutamate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618631 | glutamatic acid 340 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618631 | glutamatic acid 340 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618632 | glutamate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618633 | glutamate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618634 | fusidate / hydrocortisone Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618635 | fusidate 0.02 MG/MG / hydrocortisone 0.01 MG/MG Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618636 | fusidate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618637 | fusidate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618638 | fusidate 0.009 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618639 | fusidate 0.009 MG/MG / hydrocortisone 0.0009 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618640 | betamethasone / fusidate Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618641 | betamethasone 1 MG/ML / fusidate 20 MG/ML Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618642 | glutamate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618643 | glutamic acid 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618643 | glutamic acid 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618644 | glutamic acid 340 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618644 | glutamic acid 340 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618649 | glutamate 130 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618650 | alanine / glutamate / glycine / thiamine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618651 | Alanine 130 MG / Glutamate 130 MG / Glycine 130 MG / vit-B1 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618651 | Alanine 130 MG / Glutamate 130 MG / Glycine 130 MG / vit-B1 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618651 | Alanine 130 MG / Glutamate 130 MG / Glycine 130 MG / vit-B1 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618652 | glutamate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618653 | calcium citrate / glutamate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618654 | calcium citrate 1040 MG / glutamate 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618657 | glutamate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618658 | glutamate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618666 | glutamate 180 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618667 | betaine / glutamate / pepsin A Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618668 | betaine 120 MG / glutamic acid 180 MG / pepsin A 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618668 | betaine 120 MG / glutamic acid 180 MG / pepsin A 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618669 | alanine / glutamate / glycine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618670 | alanine 200 MG / glutamic acid 200 MG / glycine 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618670 | alanine 200 MG / glutamic acid 200 MG / glycine 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618672 | dehydrocholate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618674 | dehydrocholate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618675 | dehydrocholate / homatropine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618680 | dehydrocholate / docusate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618683 | dehydrocholate / docusate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618685 | dehydrocholate 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618686 | dehydrocholate 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618689 | dehydrocholate / papaverine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618690 | dehydrocholate 200 MG / papaverine 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618691 | dehydrocholate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618694 | dehydrocholate / homatropine / phenobarbital Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618694 | dehydrocholate / homatropine / phenobarbital Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618697 | dehydrocholate / docusate / phenolphthalein Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618704 | dehydrocholate / pancreatin / pepsin A Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618709 | dehydrocholate / dimethicone / pancreatin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618711 | dehydrocholate / pepsin A Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618712 | dehydrocholate 100 MG / pepsin A 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618713 | dehydrocholate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618714 | cascara sagrada / dehydrocholate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618715 | cascara sagrada 40 MG / dehydrocholate 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618736 | clorazepate dipotassium 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618737 | clorazepate dipotassium 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618737 | clorazepate dipotassium 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618739 | clorazepate dipotassium 22.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618739 | clorazepate dipotassium 22.5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 618739 | clorazepate dipotassium 22.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618739 | clorazepate dipotassium 22.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618739 | clorazepate dipotassium 22.5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 618740 | clorazepate dipotassium 3.75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618740 | clorazepate dipotassium 3.75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618742 | clorazepate dipotassium 5 MG / sulpiride 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618743 | clorazepate dipotassium 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618744 | clorazepate dipotassium 7.5 MG / mazindol 2.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618745 | clorazepate dipotassium 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618746 | clorazepate dipotassium 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618747 | clorazepate dipotassium 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618748 | clorazepate dipotassium 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618749 | astemizole 5 MG / clorazepate dipotassium 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 61875 | Noroxycodone | Designated preferred name (PT) | NO | |
| RxCUI: 61875 | Noroxycodone | Full form of descriptor (FN) | NO | |
| RxCUI: 618750 | clorazepate dipotassium 10 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618751 | clorazepate dipotassium 7.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618751 | clorazepate dipotassium 7.5 MG Oral Capsule | Designated preferred name (PT) | NO | |
| RxCUI: 618751 | clorazepate dipotassium 7.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618751 | clorazepate dipotassium 7.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618751 | clorazepate dipotassium 7.5 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 618755 | clorazepate dipotassium 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618756 | clorazepate dipotassium 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618757 | clorazepate dipotassium 22.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618758 | clorazepate dipotassium 15 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618759 | clorazepate / domperidone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618760 | clorazepate dipotassium 5 MG / domperidone 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618761 | clorazepate dipotassium 7.5 MG / mazindol 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618762 | clorazepate dipotassium 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618763 | clorazepate dipotassium 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618764 | clorazepate dipotassium 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618771 | gamma-aminobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618773 | gamma-aminobutyrate Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618776 | gamma-aminobutyrate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618778 | gamma-aminobutyrate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618781 | gamma-aminobutyrate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618782 | gamma-aminobutyrate 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618782 | gamma-aminobutyrate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618783 | vitamin B6 / zinc picolinate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618784 | pyridoxine 10 MG / zinc picolinate 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618784 | pyridoxine 10 MG / zinc picolinate 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618785 | pancreatin / vitamin B6 Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618786 | pancreatin 2000 MG / vitamin B6 3 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618787 | acetaminophen / pamabrom / vitamin B6 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618789 | vitamin B6 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618790 | melatonin / vitamin B6 Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618791 | melatonin 0.3 MG/ML / vitamin B6 0.1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618792 | pyridoxine HCl 100 MG / riboflavin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 618792 | pyridoxine HCl 100 MG / riboflavin 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618793 | tryptophan / vitamin B6 Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618794 | pyridoxine HCl 2 MG / tryptophan 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618794 | pyridoxine HCl 2 MG / tryptophan 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618796 | chromium picolinate / vitamin B6 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618797 | chromium picolinate 0.4 MG / vitamin B6 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 618797 | chromium picolinate 0.4 MG / vitamin B6 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618797 | chromium picolinate 0.4 MG / vitamin B6 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 61884 | Aralkyl acylamidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 61884 | Aralkyl acylamidase | Designated preferred name (PT) | NO | |
| RxCUI: 61884 | Aralkyl acylamidase | Full form of descriptor (FN) | NO | |
| RxCUI: 618932 | meclizine / vitamin B6 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618934 | vitamin B6 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618937 | vitamin B6 16.67 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618938 | meclizine / vitamin B6 Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618939 | meclizine 8.33 MG/ML / vitamin B6 16.67 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618940 | taurine / vitamin B6 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618941 | taurine 500 MG / vitamin B6 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618942 | doxylamine / vitamin B6 Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618946 | vitamin B6 / zinc picolinate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618947 | pyridoxine HCl 10 MG / zinc picolinate 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 618947 | pyridoxine HCl 10 MG / zinc picolinate 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618948 | vitamin B6 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618949 | vitamin B6 Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618950 | vitamin B6 40 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618951 | buclizine / vitamin B6 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618957 | benzoate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618958 | benzoate / phenylacetate Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618962 | chromium picolinate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 618963 | calcium phosphate / chromium picolinate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618964 | calcium phosphate 61 MG / chromium picolinate 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618968 | chromium picolinate / levocarnitine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 618968 | chromium picolinate / levocarnitine Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618969 | chromium picolinate 0.2 MG / levocarnitine 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 618969 | chromium picolinate 0.2 MG / levocarnitine 200 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 618970 | canrenoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 618974 | 4-aminobenzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 618975 | 4-aminobenzoate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 618976 | 4-aminobenzoate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 618977 | potassium aminobenzoate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 618977 | potassium aminobenzoate 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 618977 | potassium aminobenzoate 500 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 618977 | potassium aminobenzoate 500 MG Oral Capsule | Full form of descriptor (FN) | YES |